Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05415761 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
A NA study of Tobacco Use Cessation, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 1,332
- Enrollment target
- 1
- Study location
NCT05415761: Recruiting NA study of Tobacco Use Cessation, sponsored by University of Florida.
NCT05415761 is a NA study of Tobacco Use Cessation that is actively recruiting participants, run by University of Florida. The registered enrollment target is 1,332 participants, above the 848-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (57% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05415761, a NA study of Tobacco Use Cessation, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,332 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the comparative effectiveness of three smoking cessation therapies: mobile health (mHealth) application iCanQuit, mHealth application iCanQuit + Motiv8, and the Florida quit line.
Primary Outcome
negative CO breath sample ≤ 5 ppm using an iCO monitor, and self-reported abstinence from smoking in the last 7 days
Conditions Studied
Interventions
- BEHAVIORAL iCanQuit
- BEHAVIORAL iCanQuit+Motiv8
- BEHAVIORAL Florida quit line
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,332 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05415761 shows while recruiting
NCT05415761 is an interventional study that assigns participants to a tested intervention. Its 1,332 participants enrollment target places it among the larger protocols in the corpus, above the 848-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (57% higher).
The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 3 interventions - of which iCanQuit is the first listed.
NCT05415761 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05415761 about?
NCT05415761 is a clinical study titled "Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care". This study will evaluate the comparative effectiveness of three smoking cessation therapies: mobile health (mHealth) application iCanQuit, mHealth application iCanQuit + Motiv8, and the Florida quit line.
What is the current status of trial NCT05415761?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,332 participants. The study started on 2023-05-15. Estimated completion is 2027-12-31.
What conditions does trial NCT05415761 study?
This clinical trial studies the following conditions: Tobacco Use Cessation.
What interventions are being tested in trial NCT05415761?
The interventions under investigation include: iCanQuit (BEHAVIORAL), iCanQuit+Motiv8 (BEHAVIORAL), Florida quit line (BEHAVIORAL).
Who is sponsoring clinical trial NCT05415761?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05415761 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05415761's enrollment target sits among peer trials
1,332 9th of 36 higher than 28 of 36 other Tobacco Use Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
RECRUITING · NA
-
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
RECRUITING · NA
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05511298 · 1,332 participants
Empowering Students Project
- NCT06934876 · 1,332 participants
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
- NCT06972056 · 1,335 participants · Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- NCT05536011 · 1,329 participants
WAKIX® (Pitolisant) Pregnancy Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI